Detalhe da pesquisa
1.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
N Engl J Med
; 387(16): 1445-1455, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260792
2.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. Reply.
N Engl J Med
; 388(3): 284, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652365
3.
Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study.
J Am Acad Dermatol
; 82(2): 412-419, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31622643
4.
Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas.
J Invest Dermatol
; 143(8): 1388-1396, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294242
5.
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100â¯×â¯109/L): Final Analysis of an Open-Label Phase 2 Study.
Clin Lymphoma Myeloma Leuk
; 22(5): 336-346, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911667
6.
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
J Hematol Oncol
; 10(1): 55, 2017 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28228106